论文信息 - Are manufacturers sharing data as promised? - 字舞流文

Are manufacturers sharing data as promised?

The drug industry’s rhetoric over transparency of clinical trial data may not be reflected in practice

Kay Dickersin | Peter Doshi | Evan Mayo-Wilson | E. Mayo-Wilson | K. Dickersin | P. Doshi

[1] M. Kieny,et al. Rationale for WHO's New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results , 2015, PLoS medicine.

[2] Jeffrey M Drazen,et al. Sharing individual patient data from clinical trials. , 2015, The New England journal of medicine.

[3] Bartha M. Knoppers,et al. Data sharing, year 1--access to data from industry-sponsored clinical trials. , 2014, The New England journal of medicine.

[4] Kristian Thorlund,et al. Reanalyses of randomized clinical trial data. , 2014, JAMA.

[5] Karen Wells,et al. Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach. , 2014, Pharmaceutical statistics.

[6] P. Doshi. From promises to policies: is big pharma delivering on transparency? , 2014, BMJ : British Medical Journal.

[7] Harlan M Krumholz,et al. Increasing value and reducing waste: addressing inaccessible research , 2014, The Lancet.

[8] Iain Chalmers,et al. How to increase value and reduce waste when research priorities are set , 2014, The Lancet.

[9] K. Dickersin,et al. Metabias: A Challenge for Comparative Effectiveness Research , 2011, Annals of Internal Medicine.